# Bifidobacterium breve Yakult

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/bifidobacterium-breve-yakult
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-25
**Evidence Score:** 6 / 10
**Category:** Fermented/Probiotic
**Also Known As:** Bifidobacterium breve Yakult, B. breve Yakult, BbrY, Bifidobacterium breve strain Yakult, B. breve BbrY, Yakult probiotic strain

## Overview

Bifidobacterium breve Yakult is a proprietary [probiotic](/ingredients/condition/gut-health) strain that produces bacteriocins and short-chain fatty acids to modulate gut microbiota composition. This strain specifically supports skin barrier function through the gut-skin axis and reduces toxic phenol compound accumulation.

## Health Benefits

• May support skin hydration and barrier function - one RCT showed prevention of hydration level decreases in the stratum corneum (Moderate evidence, PMID: 4034291)
• Reduces serum and urine phenol levels - clinical trial demonstrated decreased phenol [metabolism](/ingredients/condition/weight-management) over 4 weeks (Moderate evidence, PMID: 4034291)
• May improve gastrointestinal symptoms when combined with other [probiotic](/ingredients/condition/gut-health)s - one study found symptom improvement with decreased hydrogen production (Preliminary evidence, PMID: 22402407)
• Demonstrated colonization ability - human feeding experiments confirmed survival through GI tract with fecal recovery exceeding 10⁹ CFU/g (Strong evidence)
• Failed to maintain ulcerative colitis remission - large RCT (n=195) showed no benefit vs placebo for UC maintenance (Strong negative evidence, PMID: 29450747)

## Mechanism of Action

Bifidobacterium breve Yakult colonizes the intestinal tract and produces butyrate, acetate, and propionate, which strengthen [intestinal barrier integrity](/ingredients/condition/gut-health). The strain metabolizes phenolic compounds through phenol hydroxylase enzymes, reducing systemic phenol absorption. Through the gut-skin axis, improved intestinal permeability and reduced [inflammatory](/ingredients/condition/inflammation) cytokines enhance stratum corneum hydration and barrier function.

## Clinical Summary

One randomized controlled trial demonstrated that Bifidobacterium breve Yakult prevented decreases in stratum corneum hydration levels, showing moderate evidence for skin barrier support. A clinical trial over 4 weeks showed significant reductions in both serum and urine phenol levels, indicating effective phenol detoxification. However, research is limited with small sample sizes and relatively short study durations. More large-scale, long-term trials are needed to establish definitive clinical benefits.

## Nutritional Profile

Bifidobacterium breve Yakult is a [probiotic](/ingredients/condition/gut-health) microorganism, not a conventional food ingredient, so macronutrient and micronutrient content is not applicable in traditional dietary terms. The preparation typically delivers live bacterial cells measured in colony-forming units (CFU); commercial Yakult formulations contain approximately 6.5 billion CFU (6.5 × 10⁹) of B. breve Yakult per 65ml serving, though specific B. breve Yakult strains are also delivered in capsule or powder formats at varying CFU counts (typically 10⁹ to 10¹⁰ CFU per dose in research settings). The bioactive components of functional relevance include: (1) cell wall constituents such as lipoteichoic acids and peptidoglycans, which interact with host toll-like receptors (TLR-2, TLR-4) to modulate immune signaling; (2) exopolysaccharides (EPS) produced by the strain, which contribute to gut mucosa adhesion and [immunomodulatory](/ingredients/condition/immune-support) effects; (3) short-chain fatty acids (SCFAs) — primarily acetate — generated as fermentation metabolites in the colon, with acetate being the predominant SCFA produced by Bifidobacterium species generally; (4) B-group vitamins, particularly folate (B9) and riboflavin (B2), which Bifidobacterium species are known to biosynthesize in situ in the gut, though quantities are strain- and substrate-dependent and not precisely quantified for this specific strain; (5) conjugated linoleic acid (CLA) precursor activity has been noted in some Bifidobacterium strains but is not confirmed at specific concentrations for B. breve Yakult. Bioavailability context: as a live organism, the 'nutrient delivery' is indirect — benefits arise from colonization, fermentation activity, and host-microbe signaling rather than direct nutrient absorption. Survival through gastric acid is strain-dependent; B. breve Yakult has demonstrated gastric acid and bile salt tolerance in vitro, supporting sufficient viable cell delivery to the colon. The bacterial cells themselves contribute negligible macronutrient load (protein, fat, carbohydrate) at typical dosing concentrations.

## Dosage & Preparation

Clinically studied dosage: 10 billion CFU of B. breve strain Yakult per daily pack (100 mL fermented milk), often combined with 1 billion CFU L. acidophilus, administered for 4-48 weeks. Powder formulation with galacto-oligosaccharide has been used for up to 1 year. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Bifidobacterium breve Yakult is generally well-tolerated with minimal reported adverse effects in healthy individuals. Mild gastrointestinal symptoms like bloating or gas may occur during initial supplementation. Immunocompromised patients should consult healthcare providers before use due to theoretical risk of bacteremia. Safety during pregnancy and lactation has not been established, requiring medical supervision for use in these populations.

## Scientific Research

The B-FLORA trial (PMID: 29450747, 19616336), a double-blind RCT with 195 Japanese UC patients, found no significant effect on maintaining relapse-free survival over 48 weeks, leading to early discontinuation. However, a skin hydration RCT (PMID: 4034291) in healthy females demonstrated positive effects on skin barrier function and phenol [metabolism](/ingredients/condition/weight-management). Earlier research suggested potential benefits for UC when combined with galacto-oligosaccharide as a synbiotic.

## Historical & Cultural Context

The search results do not provide information regarding historical or traditional use of Bifidobacterium breve. This strain represents a modern, scientifically developed [probiotic](/ingredients/condition/gut-health) rather than a traditional botanical or herbal ingredient with documented historical use.

## Synergistic Combinations

Lactobacillus acidophilus, galacto-oligosaccharide (GOS), Lactobacillus casei Shirota, soy protein

## Frequently Asked Questions

### What is the recommended dosage of Bifidobacterium breve Yakult?

Clinical studies typically use 1-10 billion CFU daily, though specific dosing varies by product formulation. The 4-week phenol reduction study used approximately 5 billion CFU daily. Consult product labels or healthcare providers for specific dosing recommendations.

### How long does it take for Bifidobacterium breve Yakult to show skin benefits?

Clinical trials measuring stratum corneum hydration showed preventive effects during the study period, suggesting benefits may occur within weeks. However, optimal skin barrier improvements likely require 4-8 weeks of consistent supplementation based on typical probiotic colonization patterns.

### Can Bifidobacterium breve Yakult help with phenol sensitivity?

Yes, clinical evidence shows this strain significantly reduces both serum and urine phenol levels over 4 weeks of supplementation. This suggests potential benefits for individuals with impaired phenol detoxification or sensitivity to phenolic compounds in foods.

### What foods contain Bifidobacterium breve Yakult naturally?

Bifidobacterium breve Yakult is a proprietary strain developed by Yakult and is not found naturally in foods. It is only available through specific Yakult probiotic products or targeted probiotic supplements containing this particular strain.

### Does Bifidobacterium breve Yakult survive stomach acid?

This strain demonstrates good acid tolerance and bile resistance, allowing survival through gastric transit to colonize the intestines. Yakult's proprietary cultivation methods enhance the strain's viability, though enteric-coated supplements may provide additional protection during digestion.

### Is Bifidobacterium breve Yakult safe during pregnancy and breastfeeding?

Bifidobacterium breve Yakult is generally recognized as safe (GRAS) and is commonly used in fermented foods consumed during pregnancy and lactation. However, pregnant or breastfeeding women should consult their healthcare provider before starting any new probiotic supplement to ensure it is appropriate for their individual circumstances. Clinical safety data specific to pregnancy and breastfeeding populations is limited, so individualized medical guidance is recommended.

### Does Bifidobacterium breve Yakult interact with antibiotics or other common medications?

Bifidobacterium breve Yakult may have reduced efficacy when taken concurrently with antibiotics, as antibiotics can kill beneficial bacteria. It is generally recommended to take probiotics at least 2 hours before or after antibiotic doses to maximize probiotic survival. If you are taking medications, especially immunosuppressants or anticoagulants, consult your healthcare provider before adding this probiotic to ensure no interactions occur.

### What does clinical research show about Bifidobacterium breve Yakult's effectiveness compared to other probiotic strains?

Clinical evidence for Bifidobacterium breve Yakult specifically shows moderate-quality support for skin hydration maintenance and phenol metabolism reduction based on randomized controlled trials. While individual strains have different mechanisms of action, B. breve Yakult is one of the better-characterized strains with published human studies demonstrating measurable physiological effects. Direct head-to-head comparisons with other Bifidobacterium species or multi-strain formulations are limited, making it difficult to establish definitive superiority over alternative probiotic options.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*